FGF21 and acute respiratory distress syndrome: Our analysis of disease progression in patients with sepsis and ARDS indicated the non-survivors had continuously increased serum levels of FGF21, and this was accompanied by persistent increases in the levels of multiple pro-inflammatory cytokines.